[Annual progress in pulmonary rehabilitation in 2025]
None:
This review provides a comprehensive summary of major advances in pulmonary rehabilitation (PR) research from October 2024 to September 2025. It focuses on four key domains: implementation status, expansion of disease spectrum, conceptual innovation, and technological development. Globally, PR coverage remains suboptimal, with pronounced socioeconomic disparities, poor program quality and low adherence. Evidence suggests that simplified equipment and shorter rehabilitation courses can maintain therapeutic efficacy while substantially improving accessibility. In terms of disease spectrum, PR is no longer confined to single chronic respiratory diseases but has expanded to include respiratory comorbidities. Its application timeline has advanced from post-treatment rehabilitation to early prevention. While the rapid growth of tele-rehabilitation has enhanced service reach, yet its limitations and the unique advantages of traditional center-based programs must be acknowledged. Technologically, emerging training modalities, psychological interventions, and digital intelligent systems have continually enriched rehabilitation strategies. Overall, PR is advancing towards a more precise, continuous, and universally accessible model of integrated respiratory care.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Other Pulmonary Disorders


